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Abstract The ability of 16 strains of Yarrowia lipolytica to
biotransform acetophenone and its derivatives has been stud-
ied. Thirteen of these strains were derived from a wild-type
strain Y. lipolytica A-101; six had the invertase gene (SUC2)
from Saccharomyces cerevisiae integrated into their genome,
as well as the damaged or undamaged gene encoding
orotidine-5′-phosphate decarboxylase (URA3), three had inte-
grated the damaged URA3 gene into their genome and three
were UV acetate-negative mutants, not able to growth on
acetate as the sole carbon source. The other tested strains
included two wild strains, A-101 and PMR-1, and an adenine
auxotroph ATCC 32-338A. All strains were capable of reduc-
ing acetophenone to the R-alcohol in high enantiomeric excess
(80–89 %). In all of the cultures tested, reversibility of the
reduction was observed, which led to an increase in the
enantiomeric excess. nantioselective reduction of the
acetophenone halogen derivatives revealed that the nature
and location of the halogen atom had a significant influence
on the enantioselectivity of the reduction. In the culture of
ATCC 32-338A, after a 3-day biotransformation of 2,4′-
dibromoacetophenone the enantiopure R-alcohol was obtain-
ed at a rate of 100 % of substrate conversion. In conclusion,
using these invertase-containing strains or uracyl auxotrophs
provided no additional benefit in terms of biotransformation
capacity over the parental strain.
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Introduction
Yarrowia lipolytica is a dimorphic yeast that forms cream-
colored, wrinkled, rough or smooth surfaced colonies
(Domínguez et al. 2000; Perez-Campo and Domínguez
2001; Ding et al. 2004). Strains of this species have been
isolated from margarine, cereal plants, high-protein meat
products, vegetables, frozen food, wines, tar and petroleum-
contaminated soil (Wojtatowicz et al. 1993; Alkasrawi et al.
1999; Deak et al. 2000; Thevenieau et al. 2009; Robak et al.
2011). This yeast can grow on many nutrients, including
glucose, fructose, organic acids, alcohols, acetate or hydro-
phobic substances, such as fatty acids and alkanes
(Wojtatowicz et al. 1991; Ravindra 2000), but growth is
thiamine-dependent. It has outstanding physiological and bio-
chemical properties, mainly due to the ability to use uncon-
ventional carbon sources and the secretion of extracellular
hydrolases. Y. lipolytica is capable of growth on waste sub-
strates, such as hydrolyzed molasses, spent sulfite liquor and
raw glycerol, and therefore can qualify as a producer of cheap
single cell biomass (SCB). This biomass is a valuable source
of vitamins, exogenous amino acids and unsaturated fatty
acids for animal feed (fodder yeasts) (Juszczyk et al. 2005).
Moreover, in terms of human health, yeast proteins contain
more of the exogenous amino acids (lysine, leucine,
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methionine) than algal and plant proteins (Ravindra 2000).
Because of its proteolytic and lipolytic activities, this yeast is
used in cheese production, particularly in the ripening process
(Wojtatowicz et al. 2001; Lanciotti et al. 2005; Czajgucka
et al. 2006).
Yarrowia lipolytica is capable of synthesizing lactones
through the transformation of fatty acids (Pagot et al. 1998).
One of the products is gamma-decalactone of peach aroma,
produced from castor oil (Wojtatowicz et al. 1991; Fantin et al.
2001). Other valuable products are organic acids, such as
citric, isocitric, oxoglutaric and pyruvic acids (Morgunov
et al. 2004, 2013; Finogenova et al. 2005; Thevenieau et al.
2009) and erythritol (Tomaszewska et al. 2014; Mirończuk
et al. 2014). Therefore, it is a species of great biotechnological
importance in biosynthesis, biodegradation and biotransfor-
mation processes (Bankar et al. 2009; Coelho et al. 2010;
Robak et al. 2011; Żogała et al. 2012; Rywinska et al. 2013).
Nowadays Y. l i po l y t i ca i s c a t ego r i zed as a
hemiascomycetous yeast, however phylogenetically it is dis-
tantly related to Saccharomyces cerevisiae (Sherman et al.
2004; Richard et al. 2005; Acker et al. 2008; Mekour et al.
2010; Naumova et al. 2010). The genome of Y. lipolyica was
sequenced 10 years ago (Casaregola et al. 2000; Sherman
et al. 2004) and unusual characteristics were found. The most
important of these are its size (20.5 Mbp, twice the size of the
S. cerevisiae genome), considerably high contents of G+C
(49 %), the presence of 1,119 introns, chromosomal features
of atypical structure (centromers and replication origins), a
large number of tRNA genes (510), dispersed 5S rRNA genes
(109 copies) and a novel organization of RNA genes (Acker
et al. 2008; Mekour et al. 2010). The focus of much current
research is the the study of new aspects of gene expression
regulation (Neuveglise et al. 2005; Mekour et al. 2010; Blazek
et al. 2011), which has resulted in the description of new
phylogenetically related species (Knutsen et al. 2007; Michely
et al. 2013).
Yarrowia lipolytica metabolizes only a few monosaccha-
rides, namely, glucose, fructose, mannose and ribose. It cannot
utilize polysaccharides and disaccharides, such as sucrose or
lactose (Madzak et al. 2004; Morgunov et al. 2004; Rywinska
et al. 2013). Since the 1980s there have been a persistent effort
to effect the genetic improvement and development of
Y. lipolytica strains, with a focus the efficient production of
heterologous proteins or organic acids (Gasmi et al. 2001,
2011; Nicaud 2012).
One relatively easy approach to select potential new pro-
ducers can be selection based on the ability to metabolize a
non-typical (for the species under study) source of carbon, i.e.
sucrose. Sucrose undergoes hydrolysis to glucose and fructose
in the reaction catalyzed by an invertase, the enzyme encoded
by the SUC2 gene in S. cerevisiae. Strains of Y. lipolytica
containing invertase (Suc+) have been obtained by Nicaud
et al. (1989), Förster et al. (2007) and Walczak and Robak
(2009). Due to their capacity to grow on sucrose, recombinant
strains of Y. lipolytica can utilize sucrose-containing sub-
strates, such as non-hydrolyzed molasses and table sugar
(Nicaud et al. 1989; Li et al. 2012). Y. lipolytica transformants
with the Suc+ phenotype differ by various metabolic proper-
ties from the parental strain (Lazar et al. 2011, 2013; Michely
et al. 2013) and therefore can be regarded as having a novel
biotransformation ability.
Growing interest in the synthesis of enantiomerically pure
compounds has promoted a great development in biocatalysis.
Biotransformation is a convenient method for preparing chiral
compounds. Chiral alcohols have been prepared through the
reduction of aromatic ketones using yeast, fungi, bacteria,
plants and isolated enzymes as biocatalysts. Enantiopure al-
cohols are useful chiral building blocks in the asymmetric
synthesis of bioactive compounds of complex structures
(Linder et al. 1989; Yadav et al. 2001; White et al. 2006;
Janeczko et al. 2013). For this reason, studies on effective
ways of obtaining these compounds on a preparative scale
have been undertaken. The asymmetric reduction of ketones
with the help of biocatalysts is a method that fulfills green
chemistry requirements (Nakamura et al. 2003). In recent
years several reports on the employment of isolated dehydro-
genases for enantiospecific reduction have appeared (Zhu
et al. 2009; Hoff and Sundby 2013; Xu et al. 2013; Rodríguez
et al. 2014). The alcohol dehydrogenase from the hyperther-
mophilic archaeon Pyrococcus furiosus (PFADH) effectively
catalyzes the reduction of various substituted α-
chloroacetophenones to form the (R)-enantiomers of the cor-
responding chlorohydrins with an excellent enantiomeric pu-
rity (Zhu et al. 2009; ). However, the employment of intact
microorganism cells of both growing and resting-state cultures
eliminates problems with the regeneration of co-factors
cooperating with enzymes. The associated low costs and
simplicity of the microbial reduction of the carbonyl group
make this experimental procedure an interesting alternative to
methods which use synthetic catalysts (Coelho et al. 2010).
As substrates for the tests reported here we have chosen α-
halogen derivatives of acetophenone because products of their
reduction are used as chiral synthons in the pharmaceutical
industry. The examples used here are the syntheses of (R)-(−)-
formoterol, (R)-(−)-isoproterenol, (R)-(−)-salmeterol, (R)-(−)-
denopamine, D-sotalol and (R)-(−)-clorprenalin (Corey and
Helel 1998; Goswami et al. 2001), which are important
beta2-adrenergic receptor agonist drugs.
The aim of this study was to test 16 strains of Y. lipolytica
for their ability to transform acetophenone and its halogen
derivatives. Nine strains are new, derived from a wild-type
Y. lipolytica strain A-101, by genetic transformation (Walczak
and Robak 2009). With the help of gene engineering tool,s
some of transformants were obtained by homologous integra-
tion into the genome of the SUC2 gene (clones Suc+ura−) and
others by non-homologous gene integration (clones Suc+Ura+
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and suc−ura−). One of the clones obtained had two copies of
the invertase gene (Lazar et al. 2011). All of these strains
could potentially manifest new biotransformation properties.
Materials and methods
Substrates and strains
The substrates used in this study are acetophenone (1), 2,4′-
dichloroacetophenone (3), 2,2’,4′-trichloroacetophenone (4),
2-chloro-4 ′-f luoroacetophenone (5) , 2-bromo-4 ′-
chloroacetophenone (6) and 2,4′-dibromoacetophenone (7);
all were purchased from Sigma-Aldrich (St. Louis, MO). All
racemic alcohols (2, 8–12) were prepared by reducing the
corresponding ketone with sodium borohydride in methanol.
The strains of Y. lipolytica were obtained from the Depart-
ment of Biotechnology and Food Microbiology, Wrocław
University of Environmental and Life Sciences and included
(1) A-101 (wild-type parental strain), (2) A-101-1.31 (acetate-
negative UV mutant of A-101), (3) A-101-1.31-K1 (smooth
segregant of acetate-negative UV mutant of A-101-1.31), (4)
A-101-1.22 (acetate-negative UV mutant of A-101), (5)
PMR-1 (isolated from soil contaminated by fuel) and (6)
ATCC 32-338A (adenine auxotroph purchased from the
American Type Culture Collection). Also tested were
transformants of A-101: (7) A18 (Suc+ura−), (8) B54-6
(Suc+ura−), (9) B55-3 (Suc+ura−), (10) B14-6 (Suc+ura−),
(11) B57-4 (Suc+ura−), (12) B1-1 (suc−ura−), (13) A50
(suc−ura−), (14) B9-2 (suc−ura−), (15) Klon1 (Suc+Ura+) and
(16) B56-5 (Suc+Ura+).
Strains numbers 7–16 underwent genetic transformation by
a yeast cassette carrying the SUC2 invertase gene from
S. cerevisaie, flanked by two ura3 sequence fragments, ho-
mologous to the native URA3 gene, encoding orotidine-5′-
phosphate decarboxylase from Y. lipolytica. Using the trans-
formation procedure described byWalczak and Robak (2009),
we obtained three groups of recombinants. The first group
(#8–11) consisted of four strains recombined at the desired
site, characterized by the Suc+ura− phenotype. The second
group (#12–14) contained suc−ura− strains, in which the cas-
sette was not fully exchanged and, therefore, these strains did
not gain the ability to grow on sucrose and become uracil
auxotrophs. The third group (#15, 16) were strains in which
the DNA hybridization took place at a location other than the
target location, giving the strains the Suc+Ura+ phenotype.
Y. lipolytica transformant B56-5 has two invertase encoding
genes (Lazar et al. 2011).
Culture media
The YPG growth medium was prepared with yeast extract
(10 g/l), peptone (20 g/l) and glucose (20 g/l) and was
sterilized in an autoclave at 121 °C for 20 min. Thiamine
(0.3 mg/l) and uracil (20 mg/l) were added after sterilization.
The minimal growth medium MMT containing sucrose
was prepared by mixing the following ingredients in 100 ml
of water: (NH4)H2PO4 (5 g/l), KH2PO4 (2.5 g/l), MgSO4⋅
7H2O (1 g/l) and 1 ml/l of mineral salts [Ca(NO3)2 ⋅ 4H2O
(2 g) , Na2MoO4 (20 mg), FeCl3 ⋅6H2O (200 mg), CuSO4 ⋅
5H2O (10 mg), H3BO3 (50 mg), CoCl2 (10 mg), MnSO4 ⋅
4H2O (40 mg), KI (10 mg), ZnSO4 ⋅7H2O (40 mg). After
sterilization in an autoclave, sucrose (10 g/l), thiamine
(0.3 mg/l) and uracil (20 mg/l) were added.
Growth conditions
For the analytical tests the biological material stored on agar
slants was transferred into 250ml Erlenmeyer flasks contain-
ing 50 ml of YPG or MMT medium with the appropriate
additives. Then flasks with the cultures were then placed on
a shaker (150 rpm) for 24 h at 25 °C.
For the preparative-scale biotransformations, yeasts cul-
tures were cultivated in 2,000-ml Erlenmeyer flasks contain-
ing 500 ml of YPG medium with appropriate additives on a
shaker (150 rpm) for 24 h at 25 °C.
Screening procedure
For the analytical tests the cultures were centrifuged under
aseptic conditions (21,460 g for 10 min at 25 °C), and the
biomass [number of cells≈5 ×108 (cell/ml)] was transferred
into 250-ml Erlenmeyer flasks containing 50 ml of previously
sterilized phosphate buffer (1/15 M, pH 6.47). After transfer-
ring the biomass to the buffer, 10 mg of a substrate dissolved
in 1 ml of acetone was added. After 1, 3, 6 or 9 days of
incubation at room temperature and continuous shaking
(150 rpm at 25 °C), 10-ml samples of the transformation
mixture were removed. All procedure were carried out under
aseptic conditions in microbiological safety cabinets (TopSafe
1.5, BIOAIR) or laminar flow clean benches (BIO 48,
FASTER). The samples were extracted with 10 ml of CHCl3,
dried over MgSO4, concentrated in vacuo and analyzed by
GC. All the experiments were repeated three times.
Preparative biotransformation
For the preparative-scale biotransformation the substrates
(200 mg of each of compounds dissolved in 2 ml of acetone)
were added to the cultures cultivated in 2,000-ml flasks (each
containing 500 ml of the culture). The biotransformation
mixtures were incubated under the same conditions
(150 rpm, 25 °C) for 48 h. The mixtures were then extracted
three times with 300 ml of CHCl3, dried over MgSO4 and
concentrated in vacuo. Transformation products were separat-
ed by column chromatography using silica gel (Kieselgel 60,
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230–400 mesh; Merck & Co., Whitehouse Station, NJ) and a
hexane/acetone mixture (3:1, v/v) as the eluent.
Analytical methods
The course of both the biotransformation and oxidation pro-
cesses were followed using thin layer chromatography (TLC),
and the composition of each product mixture was determined
by capillary gas chromatography (CGC). Analytical TLC was
carried out on silica gel G (Merck) with different developing
systems. Compounds were detected by spraying the plates
with 1 % Ce(SO4)2 and 2 % H3[P(Mo3O10)4] in 10 %
H2SO4. GC analysis was performed using a Hewlett-
Packard 5890A (Series II; Hewlett-Packard Co., Palo Alto,
CA) GC instrument fitted with a flame ionization detector
(FID). A chiral capillary column [Chrompack WCOT Fused
Silica (CP Chirasil-DEX CB)], 25 m×0.25 mm×0.25 μm,
(Varian Inc., Lake Forest, CA, ) was used to determine the
composition of the unreacted substrates and product mixtures.
Nuclear magnetic resonance (NMR) spectra were recorded
with a DRX 500-MHz Bruker spectrometer (Bruker Corp.,
Billerica, MA) andmeasured in CDCl3. Optical rotations were
measured with an Autopol IVautomatic polarimeter (Rudolph
Research Analytical, Hackettstown, NJ).
The GC conditions were an injector temperature of 200 °C
and a detector temperature of 250 °C. The temperature pro-
grams for enantiomeric resolution of particular compounds
are as follows:
& 1-phenylethan-1-ol (2): 90 °C/1 min, 3 °C min−1 to
105 °C, 30 °C min−1 to 200 °C/5 min, Rt (R) 4.97 min,
Rt (S) 5.42 min.
& 2,4′-dichloro-1-phenylethan-1-ol (8): 142 °C/1 min,
2 °C min−1 to 165 °C, 30 °C min−1 to 200 °C/5 min, Rt
(S) 10.05 min, Rt (R) 10.69 min.
& 2,2′,4′-trichloro-1-phenylethan-1-ol (9): 165 °C/1 min,
2 °C min−1 to 178 °C, 20 °C min−1 to 200 °C/5 min, Rt
(R) 6.84 min, Rt (S) 7.42 min.
& 2-chloro-4′-fluoro-1-phenylethan-1-ol (10): 140 °C/1min,
2 °C min−1 to 150 °C, 20 °Cmin−1 to 200 °C/5 min, Rt (R)
4.24 min, Rt (S) 4.64 min.
& 2-bromo-4′-chloro-1-phenylethan-1-ol (11): 160 °C/
1 min, 2 °C min−1 to 178 °C, 20 °C min−1 to 200 °C/
5 min, Rt (R) 9.49 min, Rt (S) 9.93 min.
& 2,4′-dibromo-1-phenylethan-1-ol (12): 150 °C/1 min,
2 °C min−1 to 183 °C, 20 °C min−1 to 200 °C/5 min, Rt
(R) 14.20 min, Rt (S) 14.73 min.
Identification of products
The obtained products proved to be secondary alcohols. The
locations and orientations of the newly formed hydroxyl
groups were determined on the basis of chemical shifts and
shapes of the CHOH signals in the 1H NMR spectra:
& (R)-1-phenylethan-1-ol (2) [α]D
20 = +38.6° (c=3.0 CHCl3)
(79 % ee); {Omori et al. (2007) [α]D
20 = +51°, 99 %
enantiomeric excess (ee)}; 1H NMR (CDCl3) δ 1.47 (d,
3H, J=6.5 Hz, CH3), 2.79 (s, 1H, OH), 4.79 (q, 1H, J=
6.5 Hz, CH–OH), and 7.14-7.21 (m, 5H, H–Ar).
& (S)-2,4’-dichloro-1-phenylethan-1-ol (8) [α]D
20 = +27.2°
(c=3.45 CHCl3) (86 % ee); {Wei et al. (1998), [α]D
20 = +
44.2°, 96.6 % ee}; 1H NMR (CDCl3) δ 2.67 (s, 1H, −OH),
3.60 (dd, 1H, J=11.3, 8.6 Hz, one of CH2), 3.71 (dd, 1H,
J=11.3, 3.5 Hz, one of CH2), 4.88 (dd, 1H, J=8.6, 3.4 Hz,
CH–OH), and 7.26-7.39 (m, 4H, H–Ar).
& (R)-2,2’,4’-trichloro-1-phenylethan-1-ol (9) [α]D
20 =
−26.1° (c=1.0 CHCl3) (68 % ee); (Huang and Ying
(2007), [α]D
20 = −59.1°, 90-92 % ee}; 1H NMR (CDCl3)
δ 2.82 (s, 1H, OH), 3.52 (dd, 1H, J=11.3, 8.5 Hz, one of
CH2), 3.87 (dd, 1H, J=11.3, 2.8 Hz, one of CH2), 5.26
(dd, 1H, J=8.5, 2.8 CH–OH), 7.31 (dd, 1H, J=8.3,
2.2 Hz, H5’–Ar), 7.38 (d, H1, J=2.2 Hz, H6’–Ar), and
7.58 (d, 1H, J=8.3 Hz, H3’–Ar).
& (S)-2-chloro-4’-fluoro-1-phenylethan-1-ol (10) [α]D
20 = +
34.7° (c=4.75 CHCl3) (80 % ee); {Nieduzak and
Margolin (1991), [α]D
20 = +51°, 97 % ee}; 1H NMR
(CDCl3) δ 2.73 (s, 1H, OH), 3.61 (dd, 1H, J=11.3,
8.7 Hz, one of CH2), 3.71 (dd, 1H, J=11.3, 3.5 Hz, one
of CH2), 4.88 (dd, 1H, J=8.7, 3.5 Hz, CH–OH), 7.04-7.09
(m, 2H, H3’,5’–Ar), and 7.32-7.38 (m, 2H, H2’, 6’–Ar).
& (S)-2-bromo-4’-chloro-1-phenylethan-1-ol (11) [α]D
20 = +
14.3° (c=1.2 CHCl3) (42 % ee); {Basavaiah et al. (2004),
[α]D
20 = +39.0°, 89% ee}; 1H NMR (CDCl3) δ 2.69 (s, 1H,
OH), 3.50 (dd, 1H, J=10.5, 8.8 Hz, one of CH2), 3.61 (dd,
1H, J=10.5, 3.4 Hz, one of CH2), 4.91 (dd, 1H, J=8.8,
3.4 Hz, CH–OH), and 7.20-7.28 (m, 4H, Hz, H-Ar).
& (S)-2,4’-dibromo-1-phenylethan-1-ol (12) [α]D
20 = −36.1°
(c=1.8 CHCl3) (100 % ee); {Basavaiah et al. 2004), [α]D
20
= +33.8°, 96% ee}; 1H NMR (CDCl3) δ 2.75 (s, 1H, OH),
3.49 (dd, 1H, J=10.5, 8.7 Hz, one of CH2), 3.60 (dd, 1H,
J=10.5, 3.4 Hz, one of CH2), 4.88 (dd, 1H, J=8.7, 3.4 Hz
CH–OH), 7.24-7.28 (m, 2H, H3’,5’–Ar), and 7.47-7.54
(m, 2H, H2’,6’–Ar).
Results and discussion
The aim of this research was to check the strains of
Y. lipolytica with a known phenotype and genotype with
respect to their ability to biotransform the prochiral
mixed aliphatic–aromatic ketone acetophenone. The re-
duction ability of these strains was also evaluated. Be-
cause of the reversibility of the reduction observed in
the latter experiment, biotransformations were also
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performed in a racemic mixture of 1-phenylethan-1-ol.
Additionally, we studied enantioselective reduction of
halogen derivatives of acetophenone in cultures of se-
lected strains.
In order to check the influence of SUC2 gene expression on
the biotransformation process, experiments with biomass
grown on MMT medium containing sucrose as the sole car-
bon source were also carried out.
Enantioselective reduction of acetophenone (1) in cultures
of selected strains
The ability of the parental strain Y. lipolytica A-101 and its
derivatives (A18, B54-6, B55-4, B57-4, A50, B9-2, B56-5,
B14-6, Klon1) to reduce acetophenone (1) was assessed. The
results showed that genetic modifications only slightly influ-
enced the yield of the reduction and the enantiomeric excess
of the obtained alcohol (2) (Table 1). An efficient reduction of
the substrate took place in all of the cultures, leading to the
anti-Prelog product (R)-1-phenylethan-1-ol (2) with high en-
antiomeric excess. Due to the reversibility of the
acetophenone reduction reaction in the cultures of the selected
strains (Fig. 1), the highest enantiomeric excess (ee=80–
90 %) for (R)-alcohol (2) was achieved as many as 9 days
after the biotransformation (Table 1). After 1 day of substrate
incubation, the R-alcohol was obtained with 50–60 % of
enantiomeric excess (data not shown). Our observations re-
vealed that the longer the reaction time, the higher the pre-
dominance of this enantiomer, possibly explained by the
oxidation of S-alcohol (2) back to the ketone (Figs. 1, 2). A
similar tendency was observed for the Y. lipolytica strain
ATCC 32-338A, where a gradual drop in S-alcohol content
in relation to the R-alcohol (2) was noted. However, unlike the
other tested strains, ATCC 32-338A produced predominantly
(S)-l-phenylethan-1-ol (2), which is in accordance with the
Prelog’s rule (Fig. 2).
Biotransformations of racemic 1-phenylethan-1-ol (2)
The aim of the next experiment was to confirm that the
reduction of acetophenone (1) is an equilibrium reaction.
Therefore, a racemic mixture of 1-phenylethan-1-ol (2) was
subjected to biotransformation. We observed a distinctive
decrease in (S)-1-phenylethan-1-ol amount (2) and an increase
in the R-enantiomer content of almost all tested strains after 6
(data not shown) and 9 days (Table 2) of the reaction. This
result means that in the cultures of the tested strains the S-
alcohol was oxidized to the ketone, and the formed
acetophenone was reduced to R-alcohol 2. The highest bio-
transformation yields were observed for Y. lipolytica strain A-
101 with the suc−ura− phenotype (A18 and B9-2). In the
cultures of these strains R-alcohol 2 was obtained with the
highest enantiomeric excess (Table 2; Fig. 3).
On the basis of these results we selected the following
strains for further experiments: parental strain Y. lipolytica
A-101 and the strains B56-5 (Suc+Ura+), A18 (Suc+ura−)
and A50 (suc−ura−).
Biotransformation of acetophenone by Y. lipolytica A18
and B56-5 growing on sucrose
Due to the non-typical characteristic ability of Y. lipolytica
to use sucrose as a carbon source, we cultivation all
strains on a minimal growth medium MTM containing
sucrose. The biotransformations were performed accord-
ing to the procedure described in the section Screening
procedure. The growth of the strain Y. lipolytica A18 was
considerably inhibited (number of cells 3.2×107 cells/ml)
and, therefore, the results of the reduction were poorer
(enantiomeric excess up to 71 %, but the conversion was
Table 1 Biotransformation of acetophenone (1) by selected Yarrowia
lipolytica strains (after 9 days)
Strain Conversion (%)a ee of alcohol 2 (%)
Wild strains
PMR-1 91±2 89 (R)
A-101 93±0 83 (R)
Mutants
A-101-1.22 92±2 80 (R)
A-101-1.31-K1 87±3 80 (R)
A-101-1.31 85±4 73 (R)
ATTC 32-338A 48±1 36 (S)
Clones
A18 89±3 82 (R)
B54-6 88±4 88 (R)
B55-3 94±2 93 (R)
Klon1 92±1 89 (R)
B1-1 92±4 92 (R)
A50 87±4 88 (R)
B56-5 94±1 81 (R)
B9-2 94±2 90 (R)
B14-6 92±1 79 (R)
B57-4 93±0 83 (R)
ee, Enantiomeric excess
a Values reported as the mean ± standard deviation (SD)
OH O OH
1(S)-2 (R)-2
Fig. 1 Reduction of acetophenone (1) to (R)-1-phenylethan-1-ol [(R)-2]
and to (S)-1-phenylethan-1-ol [(S)-2)] by Yarrowia lipolytica strains
Ann Microbiol (2015) 65:1097–1107 1101
only 23 % 9 days after the biotransformation). The strain
Y. lipolytica B56-5 grew better and provided a much
higher yield from the reduction (data not shown). The
enantiomeric excess was comparable to the results obtain-
ed with yeast biomass growing on the rich culture media
(YPG).
Biotransformation of halogen derivatives of acetophenone (1)
by the parental strain
We next checked the ability of the strain Y. lipolyticaA-101 to
reduce five halogen derivatives of acetophenone (1): 2,4′-
dichloroacetophenone (3), 2,2′,4′-trichloroacetophenone (4),
2-chloro-4 ′-f luoroacetophenone (5) , 2-bromo-4 ′-
chloroacetophenone (6), and 2,4′-dibromoacetophenone (7)
(Fig. 4).
It is worth noting that in the culture of Y. lipolytica A-101
the conversion was high (92–100 %) for all of the substrates
used in this experiment. As with acetophenone (1), the major-
ity of the substrateswere reduced to the anti-Prelog alcohol.
Only for the substrate with the third chlorine atom at C-2′ (4)
did we observe the opposite stereospecificity (Table 3). We
also observed that the derivatives with bromine atom at C-2
(6, 7) gave much lower enantiomeric excess (Fig. 4); for this
group of substrates the reduction was reversible only for 2-
bromo-4′-chloroacetophenone (6) (Fig. 5).
Biotransformation of 2,4′-dichloroacetophenone (3)
by selected strains derived from Y. lipolytica A-101
The tested strains of Y. lipolytica demonstrated different abil-
ities to reduce 2,4′-dichloroacetophenone (3). Y. lipolytica
B56-5 and A18, which possess the SUC2 gene, showed
properties similar to the parental strain and reduced the sub-
strate with an almost 100 % yield and high (up to 70 %


































































Fig. 2 Time-course of biotransformation of acetophenone (1) by Y. lipolytica B55-3 (a) and Y. lipolytica ATCC 32-338A (b)
Table 2 Biotransformations of 1-phenylethan-1-ol (2) by selected
Y. lipolytica strains (results after 9 days).















aValues reported as the mean ± SD

































Fig. 3 Time-course of biotransformation of 1-phenylethan-1-ol (2) by
Y. lipolytica B9-2
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of the resulting S-alcohol (8) (Table 3). The lowest both
reduction yield (60–80 %) and enantiomeric excess (up to
33 % 9 days after biotransformation) were observed for
Y. lipolytica A-101 A50 (data not shown). In this case, the
strain ATCC 32-338A also performed the reduction with the
opposite enantiospecificity, producing a poor yied of R-alco-
hol (8) (not exceeding 30 %) (Table 3).
Biotransformation of 2,2′,4′-trichloroacetophenone (4)
by the selected strain of Y. lipolytica
The presence of the additional chlorine atom in the molecule
of 2,2′,4′-trichloroacetophenone (4) explains why this com-
pound is reduced to alcohol (9) with the opposite
enantioselectivity, compared to the previous substrates. In this
product, the R-enantiomer of alcohol (9) predominated. The
results obtained are satisfactory; however, the conversion of
the substrate is less efficient than that with the parental strain.
For strain ATCC 32-338A, the conversion was much lower
than that of the other tested strains, and the enantiomeric
excess was also very low (the S enantiomer predominated)
(Table 3).
Biotransformation of 2-chloro-4′-fluoroacetophenone (5)
by selected strains of Y. lipolytica
Similarly to the parental strain Y. lipolyticaA-101, the derived
strains demonstrated a high capacity for biotransforming 2-
chloro-4′-fluoroacetophenone (5). The highest reduction
yield, comparable to that of the parental strain, was observed
for the clone with the Suc+Ura+ B56-5 phenotype. Strains A18
and A50 showed a lower substrate conversion (71 and 55 %,
respectively). The parental strain and all clones gave predom-
inantly the S-enantiomer of alcohol (10). The highest enantio-
meric excess was noted for the parental strain (80 %) and
clone B56-5 (68 %). A relatively lower enantiomeric excess
was observed for strains A18 (54 %) and A50 (48 %). The R-
enantiomer of alcohol (10) was obtained in the culture of
ATCC 32-338A , but at a low substarte conversion (12 %)
(Table 3).
Biotransformation of 2-bromo-4′-chloroacetophenone (6)
by selected strains of Y. lipolytica
The reversible reduction processes were observed (similarly to
the parental strain) in the case of the biotransformation of 2-
bromo-4′-chloroacetophenone (6) by the mutants of
Y. lipolytica A-101. Due to changes in the composition of
the reaction mixtures during incubation with the tested micro-
organisms, large differences among the results were noticed.
The yields were high and the enantiomeric excesses were low.
The parental strain produced S-alcohol (11) with an ee of
80 %, whereas strain A50, after a 1-day biotransformation,
produced the R-enantiomer at an ee of 60%. For the rest of the
tested strains almost equimolar amounts of both enantiomers
of (11) were obtained after 1 day of biotransformation. The
most effective reduction of substrate (6) was achieved in the
culture of strain ATCC 32-338A (Table 3).
Biotransformtion of 2,4′-dibromoacetophenone (7)
by selected strains of Y. lipolytica
Transformation of this substrate in the culture of strain ATCC
32-338A produced enantiopure R-alcohol (12) with a 100 %
conversion rate (after 3 days of biotransformation). Among
the strains tested, the highest enantiomeric excess (22 %) of
the R-alcohol was observed in the culture of strain Y. lipolytica
A50, after 3 days of biotransformation (Table 3). The parental
strain and the other clones reduced the substrate with a high
degree of conversion, but with low enantiomeic excess.
The asymmetric reduction of ketones is one of the most
important reactions leading to chiral alcohols, which serve as
substrates in the production of many drugs, vitamins and
chemicals used in modern agro-technology (Goswami et al.
2001; Yadav et al. 2001; Huang andYing 2007). The results of
our study indicate that the applied genetic modifications did
not have a strong influence on reactivity compared to the
parental strain. However, our results are a good starting point
for strain selection and for further optimization of biotransfor-
mation conditions, with the aim of increasing yields and
obtaining optically pure products.
In order to check the ability of the tested strains to
perform a reduction, a prochiral mixed aliphatic–aromat-
ic ketone, i.e. acetophenone (1), was used as a model





















3, 8 Cl H Cl
4, 9 Cl Cl Cl
5, 10 F H Cl
6, 11 Br H Cl
7, 12 Br H Br
Fig . 4 Halogen der iva t ives of ace tophenone (1 ) : 2 ,4 ′ -
dichloroacetophenone (3), 2,2′,4′-trichloroacetophenone (4), 2-chloro-
4′-fluoroacetophenone (5), 2-bromo-4′-chloroacetophenone (6) and 2,4′-
dibromoacetophenone (7). (2), (8–12) Racemic alcohols
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reduction of acetophenone (1) to the R-alcohol with
high enantiomeric excess. In all of the tested cultures
reversibility of the reduction was observed, leading to
an increase in enantiomeric excess. The reversibility of
the reduc t ion was s tud ied by us ing racemic
phenylethanol as a substrate for biotransformation by
the selected strains. The result was a significant de-
crease in the amount of S-phenylethanol, leading to
the R-alcohol with an ee of >50 %.
Our results indicate that neither targeted nor non-targeted
genetic modifications have any strong impact on the yield and
enantioselectivity of the enzymes responsible for the most
common microbial transformations, such as the reduction
and oxidation of xenobiotic substrates. Moreover, the clones
of the Suc+ phenotype gained the ability to conduct biotrans-
formations in growth media containing sucrose as a carbon
source, which is not a typical characteristic of Y. lipolytica
species.
Enantioselective reduction of acetophenone halogen deriv-
atives was also performed. We observed that the nature and
location of the halogen atom exerted a significant influence on
the enantioselectivity of the reduction. A 3-day transformation
of 2,4′-dibromoacetophenone (7) in the culture of ATCC 32-
338A strain resulted in the production of the enantiopure R-
alcohol (12) at a substrate conversion rate of 100 %. Such a
good result with respect to the enantiomeric excess was
Table 3 Biotransformation of
halogen derivatives of
acetophenone (1) by selected








bValues reported as the mean ± SD
Strain Substratea Day Conversion by GC (%)b ee (%) Configuration
B56-5 3 1 100 63 S
A18 1 99 68 S
ATCC 32-338A 1 20±3 65 R
9 27±4 67 R
A50 1 58±2 31 S
A-101 1 100 86 S
B56-5 4 1 89±1 39 R
3 100 42 R
A18 1 58±2 31 R
9 88±1 47 R
ATCC 32-338A 1 24±4 2 S
3 62±1 10 S
A50 1 57±2 46 R
9 100 48 R
A-101 1 100 69 R
B56-5 5 1 98±1 68 S
A18 1 59±3 54 S
9 71±3 53 S
ATCC 32-338A 1 11±1 37 R
9 12±1 48 R
A50 1 39±2 48 S
9 55±1 47 S
A-101 1 92±1 80 S
B56-5 6 1 100 12 S
A18 1 100 2 R
ATCC 32-338A 1 100 74 S
A50 1 100 60 R
A-101 1 100 16 S
9 100 55 S
B56-5 7 1 100 14 R
A18 1 100 9 R
ATCC 32-338A 1 64±3 100 R
3 100 100 R
A50 3 100 22 R
A-101 1 100 3 S
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unexpected because the other halogen derivatives were re-
duced by this strain much less effectively. This is a also
notable result because this biotransformation gave no side
products at all. In contrast, the production of additional side
products have been observed in transformations of this sub-
strate in cultures of other microorganisms (Rocha et al. 2010;
Utsukihara et al. 2007).
Despite the fact that the strains of Y. lipolytica contain less
selective alcohol dehydrogenases than some other biocatalysts
catalyzing the enantioselective reduction of acetophenone and
its halogen derivatives (Lin et al. 2009; Tokoshima et al.
2013), they do have a rare ability to reduce acetophenone to
the anti-Prelog R-alcohol. However, the aim of our study,
apart from presenting the capability of selected strains to
perform the effective reduction, was to show differences in
biocatalytic properties of strains within the same species.
Moreover, we focused our attention to the reversibility of the
reduction which takes place during biotransformation of the
tested substrates in the cultures of Yarrowia lipolytica.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
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